ATS

ATS Corporation

49
Fundamentals76/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential27/ 100

ATS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

CAT

Caterpillar Inc.

66
Fundamentals74/ 100
Valuation38/ 100
Upside potential83/ 100
Risk potential11/ 100

CAT has the edge over ATS overall, supported by stronger modeled upside and lower modeled downside.

ATS Fundamentals

MetricStatus
Healthy
Healthy
Strong
Under pressure

ATS's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.

CAT Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.

ATS PE Valuation

CHEAPFAIREXPENSIVE70x139x209x279x
CHEAPFAIREXPENSIVE70x139x209x279x
LevelPEPriceVs current
Cheap26x$8.68-49%
Fair36x$12.33-28%
Current51x$17.18—
Expensive54x$18.33+6.7%

Historical ranges are pointers, not guarantees.

ATS's PE is 51x, but its earnings don't support one, so it isn't a reliable read right now.

CAT PE Valuation

CHEAPFAIREXPENSIVE13x26x39x52x
CHEAPFAIREXPENSIVE13x26x39x52x
LevelPEPriceVs current
Cheap15x$380-37%
Fair18x$461-24%
Forward20x$605—
Current24x$605—
Expensive33x$840+39%

Historical ranges are pointers, not guarantees.

CAT has the edge over ATS in the historical PE scenario, which offers more potential upside but is not a forecast.

ATS Forward outlook

MetricOutlook
--
Decline
Stable
Weakening
Limited
Low

Analysts expect ATS's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.

CAT Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Moderate
Low

CAT has the edge over ATS on the outlook, with more favorable earnings and revenue expectations.

ATS Risk to reward

ScenarioChangePrice
Upside+36%$23.28
Downside-27%$12.62

Calculated from the latest close: $17.18 on Nov 12.

ATS trails CAT on modeled risk to reward, with less potential upside and more potential downside.

CAT Risk to reward

ScenarioChangePrice
Upside+52%$918.83
Downside-11%$541.24

Calculated from the latest close: $605.28 on Nov 12.

CAT has a better modeled risk to reward balance than ATS, with more potential upside and less potential downside.

ATS Earnings Per Share

Q3 2023: $1.16Q4 2023: $1.27Q1 2024: $1.38Q2 2024: $1.29Q3 2024: $0.92Q4 2024: $0.64Q1 2025: $-0.21Q2 2025: $-0.28Q3 2025: $-0.04Q4 2025: $0.13Q1 2026: $0.51Q2 2026: $0.34
Q3 2023: $1.16Q4 2023: $1.27Q1 2024: $1.38Q2 2024: $1.29Q3 2024: $0.92Q4 2024: $0.64Q1 2025: $-0.21Q2 2025: $-0.28Q3 2025: $-0.04Q4 2025: $0.13Q1 2026: $0.51Q2 2026: $0.34
QuarterTTM EPSYoY
Q2 2026$0.34+$0.62
Q1 2026$0.51+$0.72
Q4 2025$0.13-80%
Q3 2025-$0.04-104%
Q2 2025-$0.28-122%
Q1 2025-$0.21-115%
Q4 2024$0.64-50%
Q3 2024$0.92-21%

ATS has returned to profit: it earned $0.34 per share over the past year, after losing money the year before.

CAT Earnings Per Share

Q4 2023: $20.12Q1 2024: $22.13Q2 2024: $21.94Q3 2024: $21.55Q4 2024: $22.05Q1 2025: $20.50Q2 2025: $19.64Q3 2025: $19.46Q4 2025: $18.81Q1 2026: $20.08Q2 2026: $23.23Q3 2026: $25.48Forward: $29.73
Q4 2023: $20.12Q1 2024: $22.13Q2 2024: $21.94Q3 2024: $21.55Q4 2024: $22.05Q1 2025: $20.50Q2 2025: $19.64Q3 2025: $19.46Q4 2025: $18.81Q1 2026: $20.08Q2 2026: $23.23Q3 2026: $25.48Forward: $29.73
QuarterTTM EPSYoY
Forward$29.73+17%
Q3 2026$25.48+31%
Q2 2026$23.23+18%
Q1 2026$20.08-2%
Q4 2025$18.81-15%
Q3 2025$19.46-9.7%
Q2 2025$19.64-10%
Q1 2025$20.50-7.4%
Q4 2024$22.05+9.6%

CAT has the edge over ATS on earnings, with more consistent year-over-year improvement.

ATS Quarterly Revenue

Q3 2023: $517MQ4 2023: $529MQ1 2024: $556MQ2 2024: $488MQ3 2024: $431MQ4 2024: $458MQ1 2025: $404MQ2 2025: $518MQ3 2025: $512MQ4 2025: $534MQ1 2026: $525MQ2 2026: $488M
Q3 2023: $517MQ4 2023: $529MQ1 2024: $556MQ2 2024: $488MQ3 2024: $431MQ4 2024: $458MQ1 2025: $404MQ2 2025: $518MQ3 2025: $512MQ4 2025: $534MQ1 2026: $525MQ2 2026: $488M
QuarterRevenueYoY
Q2 2026$487.7M-5.8%
Q1 2026$525.2M+30%
Q4 2025$534.3M+17%
Q3 2025$512.1M+19%
Q2 2025$517.9M+6.1%
Q1 2025$403.7M-27%
Q4 2024$458.4M-13%
Q3 2024$430.8M-17%

ATS's revenue is growing: $488M last quarter, down 5.8% from the same quarter a year ago.

CAT Quarterly Revenue

Q4 2023: $17.1BQ1 2024: $15.8BQ2 2024: $16.7BQ3 2024: $16.1BQ4 2024: $16.2BQ1 2025: $14.2BQ2 2025: $16.6BQ3 2025: $17.6BQ4 2025: $19.1BQ1 2026: $17.4BQ2 2026: $20.5BQ3 2026: $20.7B
Q4 2023: $17.1BQ1 2024: $15.8BQ2 2024: $16.7BQ3 2024: $16.1BQ4 2024: $16.2BQ1 2025: $14.2BQ2 2025: $16.6BQ3 2025: $17.6BQ4 2025: $19.1BQ1 2026: $17.4BQ2 2026: $20.5BQ3 2026: $20.7B
QuarterRevenueYoY
Q3 2026$20.7B+17%
Q2 2026$20.5B+24%
Q1 2026$17.4B+22%
Q4 2025$19.1B+18%
Q3 2025$17.6B+9.5%
Q2 2025$16.6B-0.7%
Q1 2025$14.2B-9.8%
Q4 2024$16.2B-5%

CAT has the edge over ATS on sales, with more consistent year-over-year improvement.

ATS Free Cash Flow

Q3 2023: −$43MQ4 2023: $35MQ1 2024: $7MQ2 2024: −$36MQ3 2024: −$43MQ4 2024: $35MQ1 2025: $7MQ2 2025: $98MQ3 2025: $14MQ4 2025: $76MQ1 2026: $87MQ2 2026: $98M
Q3 2023: −$43MQ4 2023: $35MQ1 2024: $7MQ2 2024: −$36MQ3 2024: −$43MQ4 2024: $35MQ1 2025: $7MQ2 2025: $98MQ3 2025: $14MQ4 2025: $76MQ1 2026: $87MQ2 2026: $98M
QuarterFree cash flowYoY
Q2 2026$98M0%
Q1 2026$87.2M+1088%
Q4 2025$76.2M+116%
Q3 2025$14.3M+$57.7M
Q2 2025$98M+$134.1M
Q1 2025$7.3M0%
Q4 2024$35.3M0%
Q3 2024-$43.4M$0

ATS generated $276M in free cash flow over the past year, up 183% from the year before.

CAT Free Cash Flow

Q4 2023: $3.5BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3.1BQ4 2024: $2.7BQ1 2025: $579MQ2 2025: $2.6BQ3 2025: $3.1BQ4 2025: $2.7BQ1 2026: $1.1BQ2 2026: $3.8BQ3 2026: $3.7B
Q4 2023: $3.5BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3.1BQ4 2024: $2.7BQ1 2025: $579MQ2 2025: $2.6BQ3 2025: $3.1BQ4 2025: $2.7BQ1 2026: $1.1BQ2 2026: $3.8BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+19%
Q2 2026$3.8B+47%
Q1 2026$1.1B+97%
Q4 2025$2.7B+0.1%
Q3 2025$3.1B-1.5%
Q2 2025$2.6B-4.2%
Q1 2025$579M-63%
Q4 2024$2.7B-22%

CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.

ATS Total Shares

Q3 2023: 100MQ4 2023: 100MQ1 2024: 99MQ2 2024: 99MQ3 2024: 98MQ4 2024: 99MQ1 2025: 97MQ2 2025: 98MQ3 2025: 98MQ4 2025: 98MQ1 2026: 97MQ2 2026: 98M
Q3 2023: 100MQ4 2023: 100MQ1 2024: 99MQ2 2024: 99MQ3 2024: 98MQ4 2024: 99MQ1 2025: 97MQ2 2025: 98MQ3 2025: 98MQ4 2025: 98MQ1 2026: 97MQ2 2026: 98M
PeriodChange %Net change
Quarterly+1.5%+1.4M shares
1 year+0.1%+144K shares
3 years+3.5%+3.4M shares
5 years+6.5%+6M shares
Available history+6.5%+6M shares

ATS has 98M diluted shares, about the same as a year ago.

CAT Total Shares

Q4 2023: 514MQ1 2024: 497MQ2 2024: 490MQ3 2024: 487MQ4 2024: 489MQ1 2025: 477MQ2 2025: 472MQ3 2025: 471MQ4 2025: 472MQ1 2026: 466MQ2 2026: 463MQ3 2026: 461M
Q4 2023: 514MQ1 2024: 497MQ2 2024: 490MQ3 2024: 487MQ4 2024: 489MQ1 2025: 477MQ2 2025: 472MQ3 2025: 471MQ4 2025: 472MQ1 2026: 466MQ2 2026: 463MQ3 2026: 461M
PeriodChange %Net change
Quarterly-0.3%-1.6M shares
1 year-2.1%-9.9M shares
3 years-10%-51.7M shares
5 years-16%-86.7M shares
Available history-19%-107M shares

CAT has the edge over ATS on shareholder dilution, with a more favorable share count trend.

ATS Net Leverage

Q3 2023: 3.7xQ4 2023: 3.4xQ1 2024: 2.4xQ2 2024: 2.7xQ3 2024: 3.8xQ4 2024: 4.2xQ1 2025: 8.8xQ2 2025: 8.4xQ3 2025: 7.0xQ4 2025: 5.6xQ1 2026: 3.1xQ2 2026: 3.5x
Q3 2023: 3.7xQ4 2023: 3.4xQ1 2024: 2.4xQ2 2024: 2.7xQ3 2024: 3.8xQ4 2024: 4.2xQ1 2025: 8.8xQ2 2025: 8.4xQ3 2025: 7.0xQ4 2025: 5.6xQ1 2026: 3.1xQ2 2026: 3.5x
QuarterNet LeverageStatus
Q2 20263.5xElevated
Q1 20263.1xElevated
Q4 20255.6xHigh
Q3 20257.0xHigh
Q2 20258.4xHigh
Q1 20258.8xHigh
Q4 20244.2xHigh
Q3 20243.8xElevated

ATS's net debt is about 3.5 years of its operating earnings (EBITDA), down from 8.4 years a year ago.

CAT Net Leverage

Q4 2023: 1.5xQ1 2024: -0.3xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: 1.6xQ1 2025: -0.3xQ2 2025: -0.4xQ3 2025: -0.6xQ4 2025: 2.0xQ1 2026: -0.3xQ2 2026: -0.4xQ3 2026: -0.5x
Q4 2023: 1.5xQ1 2024: -0.3xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: 1.6xQ1 2025: -0.3xQ2 2025: -0.4xQ3 2025: -0.6xQ4 2025: 2.0xQ1 2026: -0.3xQ2 2026: -0.4xQ3 2026: -0.5x
QuarterNet LeverageStatus
Q3 2026-0.5xNet Cash
Q2 2026-0.4xNet Cash
Q1 2026-0.3xNet Cash
Q4 20252.0xHealthy
Q3 2025-0.6xNet Cash
Q2 2025-0.4xNet Cash
Q1 2025-0.3xNet Cash
Q4 20241.6xHealthy

CAT has the edge over ATS on leverage, with a lower net debt burden relative to earnings.

ATS Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic5.5Oversold

ATS's weekly RSI is 31 (neutral) and its Stochastic is 5 (oversold).

CAT Weekly Momentum

MetricValueStatus
RSI32.7Neutral
Stochastic6.7Oversold

CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

ATS PE vs Industrials Sector

MetricATSSector medianRelative
PE51x24x113% above
PE %785820 pts above

ATS is trading at 51x earnings, a 113% premium to the Industrials sector's median of 24x, though its earnings don't support one.

CAT PE vs Industrials Sector

MetricCATSector medianRelative
PE24x24x1.1% below
PE %695811 pts above

CAT has the edge over ATS on valuation relative to its sector.

ATS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.15% below
20 week MA$21.018% below
50 week MA$26.435% below
100 week MA$27.137% below
200 week MA$32.147% below

ATS is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.

CAT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$709.015% below
20 week MA$797.024% below
50 week MA$771.322% below
100 week MA$586.73.2% above
200 week MA$443.137% above

CAT has the edge over ATS on trend strength, trading above more of its moving averages.

ATS Yearly ROI

YearStart priceEnd priceROI
2020$16.6$17.8+7%
2021$17.8$39.4+122%
2022$39.4$32.8-17%
2023$32.8$43.1+31%
2024$43.1$30.0-30%
2025$30.0$28.4-5.3%
2026 YTD$28.4$17.2-40%

ATS has finished lower in three of the last six years. It's down 40% so far in 2026.

CAT Yearly ROI

YearStart priceEnd priceROI
2020$148.3$179.6+21%
2021$179.6$206.2+15%
2022$206.2$239.9+16%
2023$239.9$295.7+23%
2024$295.7$364.9+23%
2025$364.9$583.0+60%
2026 YTD$583.0$605.3+3.8%

CAT has the edge over ATS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key